GP Stake Sales in PE: Market Trends in General Partners Selling Their Own Interests

The sale of general partner (GP) stakes—where a PE firm sells a minority or controlling interest in its management company to a third-party investor—has evolved from a niche liquidity tool into a structural pillar of the alternative asset industry. In 2024, aggregate transaction volume in the GP stake secondary market reached approximately USD 7.2 billion globally, according to data from Jefferies, up from less than USD 2 billion in 2019. This acceleration is driven by a confluence of factors: the 2025 implementation of the Hong Kong Monetary Authority (HKMA)’s revised capital adequacy framework for Authorized Institutions (AIs), which imposes stricter risk-weighting on illiquid PE holdings; a sustained high-interest-rate environment compressing fund-level returns; and a generational leadership transition at Asia-based firms founded in the early 2000s. For Hong Kong-headquartered sponsors, GP stake sales are no longer a theoretical option but a practical mechanism to recapitalize balance sheets, retain key talent, and fund new product lines—without triggering the full liquidity event of a fund-level secondary sale. This article examines the market mechanics, regulatory guardrails, and strategic calculus behind these transactions, with specific reference to the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (Chapter 571 of the Laws of Hong Kong) and the Listing Rules of The Stock Exchange of Hong Kong Limited (HKEX).

The Mechanics of GP Stake Transactions

Structure and Valuation Dynamics

A GP stake sale involves the transfer of equity or profit-interest units in the general partner entity—typically a Cayman Islands or BVI exempted company—that manages one or more closed-end funds. The transaction can take the form of a direct sale of shares, a secondary buyout of the GP’s holding company, or a structured preferred equity injection with conversion rights. Valuation is anchored not to net asset value (NAV) in the traditional sense but to the present value of future management fees and carried interest streams, discounted at a rate that reflects the fund’s vintage, track record, and remaining life. For a typical 10-year buyout fund in its investment period, a GP stake might trade at 8–12x annualized management fee income, with a 10–20% discount applied for illiquidity and key-person risk. The SFC’s Fund Manager Code of Conduct (FMCC), specifically paragraph 4.1 on valuation of assets, requires that any such pricing methodology be documented and auditable, with independent third-party valuation reports where the transaction involves a connected party.

The Role of Continuation Vehicles

Continuation vehicles—new funds created to hold one or more assets from an existing fund—have become the dominant structural wrapper for GP stake sales in Asia. In 2023, the HKEX recorded 7 continuation vehicle listings on the Main Board, up from 2 in 2020, according to exchange filings. The structure works as follows: the GP sells a minority stake in its management company to a continuation fund, which is capitalised by institutional LPs and, increasingly, by family offices from Singapore and Hong Kong. The GP retains operational control but cedes a portion of future economics. This arrangement avoids a full fund wind-down, preserves the GP’s carried interest alignment, and provides immediate liquidity to the GP’s founding partners. The SFC’s Licensing Handbook (2024 edition) notes that such structures require the GP to maintain its Type 9 (asset management) licence in good standing, and any change in control must be notified to the SFC within 7 business days under section 132 of the Securities and Futures Ordinance (Cap. 571).

Regulatory Considerations for Hong Kong-Based GPs

SFC Licensing and Change of Control

Any GP stake sale that results in a change of control—defined as the acquisition of 35% or more of the voting shares of a licensed corporation—triggers a mandatory notification to the SFC under section 132(1) of the SFO. The SFC will assess the new controller’s fitness and properness, including its track record, financial standing, and compliance history. In practice, the SFC has taken an average of 12–16 weeks to process such applications in 2024, according to industry feedback compiled by the Hong Kong Venture Capital and Private Equity Association (HKVCA). For cross-border buyers—such as US-based fund-of-funds or Middle Eastern sovereign wealth funds—the SFC may impose additional conditions, including a requirement to maintain a local responsible officer (RO) with at least 5 years of relevant experience in Hong Kong. Failure to comply with the notification requirement can result in a fine of up to HKD 1 million and imprisonment for 2 years under section 136 of the SFO.

HKEX Listing Rules Implications for Listed GPs

For PE firms that have listed their management companies on the HKEX Main Board—such as KKR & Co. Inc. (NYSE: KKR) or The Blackstone Group Inc. (NYSE: BX), which are not HK-listed, but the principle applies—a GP stake sale may constitute a notifiable transaction under Chapter 14 of the HKEX Listing Rules. Specifically, if the sale involves a disposal of 25% or more of the GP’s total assets, it triggers a disclosure obligation under Rule 14.34. If the consideration exceeds 100% of the GP’s market capitalisation, it becomes a very substantial disposal, requiring shareholder approval and a circular. Hong Kong-listed asset managers must also consider the implications of Rule 13.09 on inside information, as any material change in the GP’s economic interest in its funds could affect share price. The HKEX’s 2023 Guidance Letter HKEX-GL112-23 provides further clarity on the treatment of GP stakes as “equity securities” for the purposes of the Listing Rules.

Market Trends and Buyer Composition in 2025

Institutional Buyers: Sovereign Wealth Funds and Pension Plans

The buyer base for GP stakes has shifted markedly since 2021. Sovereign wealth funds (SWFs) from the Middle East and Southeast Asia now account for approximately 40% of transaction volume globally, per data from Evercore’s 2024 Secondary Market Review. The Abu Dhabi Investment Authority (ADIA) and the Qatar Investment Authority (QIA) have both established dedicated GP stake investment teams in Hong Kong, with the latter opening a 12-person office in Central in Q3 2024. These buyers are attracted to the recurring fee income and the ability to influence fund strategy without assuming direct portfolio risk. For Hong Kong-based GPs, this trend aligns with the HKMA’s 2025 capital framework, which encourages AIs to reduce their direct PE exposure by 15–20% over the next two years—a gap that SWF capital is well-positioned to fill.

Family Offices as Strategic Counterparties

Family offices—particularly those from mainland China and Singapore—have emerged as the fastest-growing buyer segment, with transaction volumes increasing by 34% year-on-year in 2024, according to a report by Campden Wealth. Unlike institutional buyers, family offices often seek governance rights rather than pure financial returns. A typical structure involves the family office taking a board seat in the GP entity, with veto rights over new fund launches, key-person changes, and carried interest distribution. This creates a tension with the SFC’s requirement under paragraph 5.1 of the FMCC that the GP must maintain independent investment decision-making. Practitioners have resolved this by ring-fencing the family office’s governance rights to matters of corporate administration, while leaving investment discretion with the GP’s investment committee.

Pricing and Structuring Trends

Pricing for GP stakes has compressed in 2025, with average multiples falling from 14x in 2021 to 10x in early 2025, reflecting higher discount rates and increased regulatory scrutiny. The deal structure has also evolved: earn-outs tied to fund performance are now standard, with 30–40% of the total consideration deferred over 3 years and contingent on the fund meeting a 1.5x net multiple threshold. In Hong Kong, these earn-outs are typically structured as profit participation notes issued by a BVI SPV, which are then assigned to the buyer. The SFC’s 2024 circular on structured products (SFC/CP/2024/01) requires that such notes be offered only to professional investors (PI) as defined under the SFO, with a minimum subscription amount of HKD 8 million.

Strategic Implications for GPs and Their LPs

Alignment of Interests and Key-Person Risk

A GP stake sale inherently dilutes the economic alignment between the GP and its limited partners (LPs). If the GP sells 30% of its carried interest to a third party, the remaining 70% must still be sufficient to incentivise the investment team. Industry practice in Hong Kong has settled on a minimum retained carried interest of 60% for the GP’s key investment professionals, as recommended in the HKVCA’s 2023 Best Practice Guidelines. LPs increasingly demand that the GP’s stake sale agreement include a “clawback” provision—requiring the GP to repurchase the stake at a discount if the fund underperforms a 1.2x gross multiple—a term that has appeared in 22% of Hong Kong GP stake transactions in 2024, up from 8% in 2021.

Impact on Fundraising and LP Relations

The announcement of a GP stake sale can complicate a concurrent fundraising process. LPs may interpret the sale as a signal that the GP lacks confidence in its own fund economics, or that the founding partners are seeking an exit. To mitigate this, GPs typically time the sale to occur after the fund’s final close, or structure it as a “stake swap” where the buyer commits capital to the new fund in exchange for GP equity. In 2024, 18% of GP stake transactions in Asia involved such a capital commitment, according to data from Triago. The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Chapter 571, subsidiary legislation) requires that any such arrangement be disclosed in the fund’s offering memorandum under the “Conflicts of Interest” section.

Actionable Takeaways

1. Any GP stake transaction involving a change of control must be notified to the SFC within 7 business days under section 132 of the SFO, with a typical processing timeline of 12–16 weeks.
2. For HKEX-listed GPs, a stake sale exceeding 25% of total assets triggers a notifiable transaction under Chapter 14 of the Listing Rules, requiring a circular and, if above 100% of market cap, shareholder approval.
3. Earn-out structures tied to fund performance are now standard, with 30–40% of consideration deferred over 3 years and contingent on a 1.5x net multiple threshold.
4. Family office buyers increasingly seek governance rights, which must be ring-fenced from investment decision-making to comply with the SFC’s FMCC paragraph 5.1.
5. GPs should retain at least 60% of carried interest post-sale to maintain LP confidence and satisfy the HKVCA’s 2023 Best Practice Guidelines.